drugset / Trial / NCT00104624

Docetaxel in Treating Older Women With Metastatic Breast Cancer

NCT00104624 ↗

Phase 2 Terminated 53 enrolled UNICANCER
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well docetaxel works in treating older women with metastatic breast cancer and whether it helps improve the ability to perform daily activities.

Timeline

Start
2005-05
Primary completion
2007-07
Completion
2008-07

Outcome

Outcome not reported

Stopped: “Toxicity issues”

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — Intravenous